Ardelyx Statistics
NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.99-0.07 (-2.29%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ardelyx by the numbers
Ardelyx has a market capitalization of $751.6 million based on 251.37M shares outstanding. With trailing EPS of $-0.23, Ardelyx is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.0% below its 50-day average and 40.1% below its 200-day average.
Average daily trading volume is 4.46M shares, or about $13.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARDX valuation vs. peer median
| Metric | ARDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $751.60M | $766.56M | -2% |
| Forward P/E | 18.9 | 3.5 | +442% |
| Avg. volume | 4.46M | 1.87M | +139% |
Peer median across 8 companies: IVA, RIGL, OBX, ORIC, COLL, IRWD, SNDX, VSTM.
Valuation
- Market cap
- $751.60M
- Forward P/E
- 18.92
- Price / sales (latest FY)
- 1.85
- EPS (TTM)
- $-0.23
- Shares outstanding
- 251.37M
Price and trading
- Previous close
- 3.06
- Open
- 3.01
- Day range
- 2.95 – 3.08
- 52-week range
- 2.80 – 8.40
- 52-week change
- -44.83%
- Beta
- —
- Volume
- 6.20M
- Average volume
- 4.46M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 751.60M
- Forward Pe
- 18.92
- Eps
- -0.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.40
- Week52 Low
- 2.80
- Avg Volume
- 4.46M
- Shares Outstanding
- 251.37M
- Ma50
- 3.22
- Ma200
- 4.99
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -64.40%
- Pct From52w Low
- 6.79%